(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SUPERIOR PHARMACEUTICAL MANUFACTURING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SUPERIOR PHARMACEUTICAL MANUFACTURING

ST13

US500000088854854

Class

35

Filing

88854854

Registration

6263205

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/03/2026

Trademark type

Word

Nice classes

35

Filing date

03/31/2020

Registration date

02/02/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/02/2021

Last transaction

02/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

08/12/2020

First use in commerce

08/12/2020

Drawing code

4

Owner type

03

Owner location

Fountain valley, CA

Examiner

RONCORONI, LAUREN R

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

S. M. (pessoa física)

Representatives

Ali Shalchi Shalchi Law PC

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; business management servicesmanaging logisticsreverse logisticssupply chain servicessupply chain visibility and synchronizationsupply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticalsbiopharmaceuticalsradiopharmaceuticalshealth care products and medical products; invoicing services; order fulfillment services; customer service management for others in the nature of facilitating manufacturing services for customersin particularproviding production updates in the field of pharmaceutical product distribution and logistics; electronic customer ordering services in the nature of electronic processing of orders for others for pharmaceuticals pharmaceutical productsmedical products and equipmentlaboratory supplies and equipment; computerized pharmaceutical financial record-keeping for the purpose of bookkeeping and maintaining financial records and pharmaceutical inventory control services; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit to ensure on-time delivery for business purposes; operation of a telephone call center for others to assist in locating and delivering complex pharmaceuticals and radiopharmaceuticals

Publications

History of USPTO decisions and trademark events.

28 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/02/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/10/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

02/02/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/29/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

12/22/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

12/19/2020

IUAA

USE AMENDMENT ACCEPTED

12/19/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

12/11/2020

IUAF

USE AMENDMENT FILED

12/11/2020

ALIE

ASSIGNED TO LIE

12/11/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/15/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/14/2020

GNRT

NON-FINAL ACTION E-MAILED

10/14/2020

CNRT

NON-FINAL ACTION WRITTEN

10/14/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/14/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/14/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

08/12/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/30/2020

GNRT

NON-FINAL ACTION E-MAILED

06/30/2020

CNRT

NON-FINAL ACTION WRITTEN

06/30/2020

DOCK

ASSIGNED TO EXAMINER

06/19/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/07/2020

NWAP

NEW APPLICATION ENTERED

04/03/2020

Continuous trademark protection

Get notified about every new filing that threatens SUPERIOR PHARMACEUTICAL MANUFACTURING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.